North America & Europe Well being and House Monitoring Market Report 2021 with Deal with Options to Handle Varied Power Situations Corresponding to Cardiac Arrhythmia, Sleep Apnoea and Diabetes – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–Added the “Health and Home Monitoring – 10th Edition” report ResearchAndMarkets.com Offer.

The number of remotely monitored patients will grow at a compound annual growth rate (CAGR) of 16.8% and will reach €115.7 million by 2026.

The number of remotely monitored patients reached 45.6 million in 2020 as market adoption continues to grow. This number includes all patients enrolled in mHealth care programs that use connected medical devices as part of the care plan.

The main focus of this report is on home monitoring solutions that are commonly used to treat patients suffering from various chronic conditions such as cardiac arrhythmia, sleep apnea and diabetes. Other applications include remote diagnostics, compliance monitoring, and clinical trials.

Cellular connectivity remains the de facto standard communication technology for most types of connected home medical monitoring devices and will account for 51.0 million euros of connections in 2026. However, using patients’ own mobile devices as healthcare centers has become a viable alternative to remote patient monitoring and BYOD connectivity is already the preferred option in some segments. By 2026, a total of €60.5 million patients will be dependent on BYOD connectivity.

The publisher estimates that revenue from remote patient monitoring (RPM) solutions will reach 27.8 billion euros in 2020, including revenue from medical monitoring devices, mHealth connectivity solutions, care platforms and mHealth care programs. RPM revenues are projected to grow at a CAGR of 11.6 percent between 2020 and 2026, reaching EUR 53.7 billion by the end of the forecast period.

Connected medical devices accounted for 64 percent of RPM’s total sales in 2020. However, revenues for mHealth connectivity solutions, care platforms and mHealth care programs are growing faster and will account for 55 percent of total revenues in 2023 and 36 percent in 2020.

There is a strong trend to build more connectivity into medical devices to enable new services and value propositions. Sleep therapy is by far the most connected segment, dominated by ResMed and Philips. The number of monitored patients continues to grow and has more than doubled since 2017, mainly due to compliance monitoring requirements introduced in the US and France.

Implantable cardiac rhythm management (CRM) has traditionally been the largest market segment, led by companies like Medtronic, Abbott, Boston Scientific and Biotronik, which incorporated connectivity into CRM solutions two decades ago. The publisher predicts that three of the fastest growing market segments over the next six years will be glucose monitoring, airflow monitoring and connected medication solutions.

Today, leading connected healthcare players in these segments include forward-thinking incumbents as well as innovative new entrants such as Abbott, AdhereTech, Dexcom, Glooko, Hero, Insulet, Medtronic, Merck Group, Propeller Health, Senseonics and WellDoc.

Healthcare platforms are one of the fastest evolving parts of the mHealth value chain. Healthcare platforms are software solutions that enable the delivery of healthcare services remotely. Various types of grooming platforms are available in the market. General-purpose platforms can be adapted to a wide variety of use cases and often serve as the basis for the development of therapy-specific mHealth products. Companies specializing in this space include Bepatient, CareSimple, ERT, S3 Connected Health and Voluntis.

Healthcare systems around the world are currently undergoing profound change. The adoption of value-based care is spreading, and healthcare providers are looking for new solutions to provide cost-effective and improved care. In response, the use of data-driven solutions to optimize healthcare is increasing. An example is the use of self-engagement apps that rely on behavioral analytics to coach patients on how to manage their conditions.

The demand for remote patient monitoring has been further accelerated by the COVID-19 pandemic. As a result, we are now seeing increased adoption and changing regulations in favor of remote patient monitoring. The publisher believes this transformation will drive adoption of mHealth solutions and anticipates healthy growth in the mHealth industry over the next six years.

This report will enable you

  • Benefit from 30 new executive interviews with market-leading companies

  • Learn about key home health monitoring devices and services

  • Study the strategies of 126 key players in the mHealth ecosystem

  • Understand the dynamics of the health monitoring market in Europe and North America

  • Understand how wireless technology can be seamlessly integrated into medical devices

  • Assess the business opportunities in the emerging mHealth segment

  • Predict future market and technology developments

Main topics covered:

List of Figures

summary

1 The challenge of chronic diseases

1.1 Introduction

1.1.1 the aging world population

1.1.2 Lifestyle-Related Diseases

1.2 Common chronic diseases

1.2.1 Cardiac arrhythmias

1.2.2 Ischemic diseases

1.2.3 Hypertension

1.2.4 Sleep Apnea

1.2.5 Chronic respiratory diseases

1.2.6 Diabetes

1.2.7 Hyperlipidemia

1.3 Healthcare Providers and Reimbursement Schemes

1.3.1 Healthcare in Asia Pacific

1.3.2 Healthcare in Europe

1.3.3 Healthcare in North America

1.4 Regulatory Environment

2 mHealth platforms

2.1 Overview of mHealth Market

2.1.1 mHealth Market Segments

2.1.2 Medical Device Connectivity Options

2.1.3 the mHealth technology value chain

2.2 mHealth connectivity solutions

2.3 mHealth Care Delivery Platforms

3 providers of physiological monitoring solutions

3.1 Medical Devices and Remote Monitoring

3.1.1 Medical Devices Revenue by Market Segment

3.1.2 Overview of the Remote Patient Monitoring market

3.2 Cardiac Rhythm Management

3.3 Remote ECG Monitoring

3.4 Blood pressure monitoring

3.5 Coagulation Monitoring

3.6 Sleep therapy monitoring

3.7 Sleep diagnostics at home

3.8 Blood Oxygen Monitoring

3.9 Air Flow Monitoring

3.10 Glucose Level Monitoring

3.11 Miscellaneous

3.11.1 Implantable Medical Devices

3.11.2 Home hemodialysis

3.11.3 Thermometers and scales

3.11.4 Mental Health

3.11.5 Cholesterol Monitoring

4 providers of medication, AED and integrated monitoring solutions

4.1 Telemedicine and Multiparameter Monitoring Solutions

4.1.1 Overview of Telemedicine Solutions Market

4.1.2 Use cases for telemedicine solutions

4.1.3 Telemedicine Solution Providers

4.2 Medication Compliance Monitoring

4.2.1 Overview of Medication Compliance Monitoring Market

4.2.2 Use cases for medication compliance monitoring

4.2.3 Compliance Monitoring Solution Providers

4.3 Connected Automated External Defibrillators

4.3.1 Overview of Connected Defibrillator Market

4.3.2 Use cases for automated external defibrillators

4.3.3 Connected Solution Providers

5 Market Analysis and Forecasts

5.1 Market Forecasts

5.1.1 Heart Rhythm Management

5.1.2 Sleep Therapy

5.1.3 Telemedicine and multi-parameter monitoring

5.1.4 ECG Monitoring

5.1.5 Glucose Level Monitoring

5.1.6 Medication Compliance Monitoring

5.1.7 Other Medical Devices

5.2 Revenue Projections

5.2.1 Medical Monitoring Devices

5.2.2 mHealth Connectivity Solutions

5.2.3 Supply Platforms

5.2.4 mHealth Care Programs

5.3 Market Drivers and Barriers

5.3.1 An aging population increases medical costs

5.3.2 Increase in the prevalence of non-communicable diseases

5.3.3 The technology barrier of generations is disappearing

5.3.4 Staff shortages in the health sector require more efficient health services

5.3.5 Providing Financial Incentives

5.3.6 Transformation to value-based care

5.3.7 Increased focus on disease prevention

5.3.8 Substitute for Medical Monitoring

5.3.9 a slowly changing industry

5.3.10 Cyber ​​security risks from more digital solutions

5.3.11 Digitization of Pstn networks and decommissioning of 2G/3G networks

5.4 Industry Trends and Analysis

5.4.1 Consumerization of medical mHealth devices and apps

5.4.2 of common metrics on AI-driven patient engagement.

5.4.3 Large pharmaceutical companies are preparing large-scale rollouts

5.4.4 Byod is becoming a popular and viable option

5.4.5 Global adoption of telemedicine is increasing

5.4.6 Integrations are becoming increasingly important in the health data ecosystem

5.4.7 Compliance monitoring is an important factor behind home monitoring

5.4.8 Covid-19 became the catalyst that propelled mHealth into the next phase of growth

For more information about this report, visit https://www.researchandmarkets.com/r/wg3bqe

Comments are closed.